BioTech

NORTH CHICAGO, Ill., Nov. 1, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that th

Pluristem Therapeutics Inc. (PSTI) announced the receipt of a joint grant awarded by the Israeli Ministry of Defense and the Israel Innovation Authority for the development of the company's PLX cells for the treatment of burn injuries.

Charles River and Toxys have entered into an agreement to offer access to ToxTracker® in North America.

DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Ne

ViiV HC submits New Drug Application to US FDA for first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine for treatment of HIV

ROCKLAND, Mass., March 29, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada

Sobi™ to Acquire Synagis® US Rights From AstraZeneca - Creates a Platform for Global Growth - read this article along with other careers information, tips and advice on BioSpace

Novartis have appointed Susanne Schaffert, Ph.D., as the new CEO of Novartis Oncology  Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on January 1, 2019. Liz Barrett will be...

Vertex today announced the appointment of Charles Wagner as Executive Vice President and Chief Financial Officer, effective April 10, 2019.

The retailer is terminating its deal with its PBM, putting commercial and managed Medicaid beneficiaries out-of-network.